NCT07948473
Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets in Healthy Volunteers
StatusCompleted
PhasePhase 1
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Maximum Observed Plasma Concentration (Cmax)
Timeframe: From predose to 48 hours postdose in each treatment period
Area Under the Plasma Concentration-Time curve from 0 to t (AUC0-t)
Timeframe: From predose to 48 hours postdose in each treatment period
Area Under the Plasma Concentration-Time Curve From 0 to Infinity (AUC0- ∞)
Timeframe: From predose to 48 hours postdose in each treatment period
Arms and interventions
Fasted Cohort: T-RExperimental
Fasted Cohort: R-TExperimental
Fed Cohort: T-RExperimental
Fed Cohort: R-TExperimental
Drugs: Metformin hydrochloride extended-release tablets 1g
Sites
1 site in 1 country
- Clinical Trials Center, The Affiliated Hospital of Guizhou Medical UniversityGuiyang, China